Assignee
ULTRAGENYX PHARMACEUTICAL INC
US·29 granted patents·41 pending applications·41 citations·filing 2012–2025
Top patents by PatentIndex Score
70 records- 0190US11771748B2Methods for treating tumor-induced osteomalaciaULTRAGENYX PHARMACEUTICAL INC·Filed 2021·Granted Oct 3, 2023·1 cites·9 claims
- 0290US11202822B2Methods for treating hypophosphatemic disordersULTRAGENYX PHARMACEUTICAL INC·Filed 2020·Granted Dec 21, 2021·2 cites·9 claims
- 0388US9554987B2Methods and formulations for treating sialic acid deficienciesULTRAGENYX PHARMACEUTICAL INC·Filed 2013·Granted Jan 31, 2017·4 cites·22 claims
- 0486US12358976B2Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin dULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Granted Jul 15, 2025·0 cites·20 claims
- 0586US11753369B2Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Granted Sep 12, 2023·1 cites·20 claims
- 0686US10639360B2Methods for treating hypophosphatemic disordersULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted May 5, 2020·3 cites·14 claims
- 0786US9241896B2Methods and formulations for treating sialic acid deficienciesULTRAGENYX PHARMACEUTICAL INC·Filed 2012·Granted Jan 26, 2016·4 cites·12 claims
- 0886US2024245759A1Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 0986US2026077025A1Sialylated glycoprotein composition and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2025·Application pending·0 cites
- 1086US2025120936A1Compositions of triglycerides and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 1186US2025120935A1Compositions of triglycerides and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 1284US10065981B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted Sep 4, 2018·4 cites·33 claims
- 1384US2026035449A1The effective and efficient control of serum phosphate for optimal bone formationULTRAGENYX PHARMACEUTICAL INC·Filed 2025·Application pending·0 cites
- 1483US8840926B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2012·Granted Sep 23, 2014·8 cites·21 claims
- 1582US12551461B2Compositions of triglycerides and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Granted Feb 17, 2026·0 cites·5 claims
- 1682US11332438B2Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted May 17, 2022·2 cites·23 claims
- 1782US9221858B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2014·Granted Dec 29, 2015·4 cites·35 claims
- 1878US11377643B2Therapeutics for glycogen storage disease type IIIULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted Jul 5, 2022·1 cites·20 claims
- 1978US2023127775A1Methods and compositions for the treatment of amyloidosisULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 2077US10457701B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted Oct 29, 2019·1 cites·15 claims
- 2177US2022202915A1Sialylated glycoprotein compositons and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 2277US2024092731A1Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 2376US2026041788A1Gene therapy for treating propionic acidemiaULTRAGENYX PHARMACEUTICAL INC·Filed 2025·Application pending·0 cites
- 2474US9687532B2Sialylated glycoprotein compositons and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2016·Granted Jun 27, 2017·1 cites·17 claims
- 2573US10889607B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2019·Granted Jan 12, 2021·0 cites·20 claims
- 2673US10385085B2Crystal forms of sialic acid or salt or solvate thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2016·Granted Aug 20, 2019·3 cites·16 claims
- 2772US9457068B2Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted Oct 4, 2016·1 cites·9 claims
- 2871US9457067B2Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted Oct 4, 2016·1 cites·12 claims
- 2971US2019183985A1Methods and compositions for the treatment of amyloidosisULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3070US2020282028A1Sialylated glycoprotein compositons and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 3169US2021228694A1Methods and compositions for the treatment of amyloidosisULTRAGENYX PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 3268US2024252562A1Methods of heat inactivation of adenovirusULTRAGENYX PHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 3366US2022340886A1Therapeutics for glycogen storage disease type iiiULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 3465US12472268B2Gene therapy for treating propionic acidemiaULTRAGENYX PHARMACEUTICAL INC·Filed 2019·Granted Nov 18, 2025·0 cites·28 claims
- 3565US2024376440A1Engineered producer cell lines and methods of making and using the sameULTRAGENYX PHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 3664US2020069631A1Solid compositions of triglycerides and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 3764US2017157160A1Methods and formulations for treating sialic acid deficienciesULTRAGENYX PHARMACEUTICAL INC·Filed 2016·Application pending·0 cites
- 3864US2017136051A1Methods and formulations for treating sialic acid deficienciesULTRAGENYX PHARMACEUTICAL INC·Filed 2016·Application pending·0 cites
- 3963US9937243B2Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2017·Granted Apr 10, 2018·0 cites·18 claims
- 4063US2017119861A1Methods and compositions for the treatment of amyloidosisULTRAGENYX PHARMACEUTICAL INC·Filed 2016·Application pending·0 cites
- 4163US2019054153A1Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4261US2024360424A1Anion-exchange chromatography methods for purification of recombinant adeno-associated virusesULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 4361US2025230418A1Modified batch aav production systems and methodsULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 4460US2025333763A1Gene therapy constructs for treating wilson diseaseULTRAGENYX PHARMACEUTICAL INC·Filed 2025·Application pending·0 cites
- 4559US11944658B2Methods of heat inactivation of adenovirusULTRAGENYX PHARMACEUTICAL INC·Filed 2021·Granted Apr 2, 2024·0 cites·20 claims
- 4658US2025019668A1Engineered cell lines for increased production of recombinant adeno-associated virus (raav)ULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 4757US2025297251A1Certain dux4 inhibitors and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 4856US12338450B2Gene therapy constructs for treating Wilson diseaseULTRAGENYX PHARMACEUTICAL INC·Filed 2020·Granted Jun 24, 2025·0 cites·18 claims
- 4956US2025019721A1Compositions and methods for treating a muscular dystrophyULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 5056US2018147175A1Compositions and methods for treatment of movement disordersULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ULTRAGENYX PHARMACEUTICAL INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →